Survival in people with type 2 diabetes as a function of HbA1c

被引：7
|
作者：
Balkau, Beverley [1 ,2 ]
Simon, Dominique [1 ,3 ]
机构：
[1] INSERM, U1018, CESP Ctr Res Epidemiol & Populat Hlth, Epidemiol Diabet Obes & Chron Kidney Dis Lifecour, F-94807 Villejuif, France
[2] Univ Paris 11, UMRS 1018, Villejuif, France
[3] Grp Hosp Pitie Salpetriere, F-75634 Paris, France
来源：
LANCET | 2010年 / 375卷 / 9713期
关键词：
GLUCOSE CONTROL; HYPOGLYCEMIA;
D O I：
10.1016/S0140-6736(09)62192-9
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：438 / 440
页数：3
相关论文
共 50 条
  • [41] The Impact of Substantial Improvements in HbA1c and Weight Loss on the Medication Preferences of People with Type 2 Diabetes
    Gelhorn, Heather L.
    Osumili, Beatrice
    Brown, Katelyn
    Ross, Melissa M.
    Schulz, Andrea
    Fernandez, Gabriela
    Boye, Kristina S.
    PATIENT PREFERENCE AND ADHERENCE, 2023, 17 : 793 - 805
  • [42] Trends of HbA1c and BMI in People with Type 2 Diabetes: A Japanese Claims-Based Study
    Kazuo Hara
    Tetsuaki Hirase
    Swathi Pathadka
    Zhihong Cai
    Manaka Sato
    Noriyuki Ishida
    Ryo Takemura
    Diabetes Therapy, 2024, 15 : 801 - 817
  • [43] Previous Dramatic Reduction of HbA1c and Retinopathy in Type 2 Diabetes
    Larroumet, Alice
    Korobelnik, Jean-Francois
    Foussard, Ninon
    Blanco, Laurence
    Mohammedi, Kamel
    Monlun, Marie
    Rigalleau, Vincent
    DIABETES, 2019, 68
  • [44] Low HbA1c levels and mortality in type 2 diabetes mellitus
    Shamsa Ali
    Vivian A. Fonseca
    Nature Reviews Endocrinology, 2010, 6 : 359 - 360
  • [45] THE IMPACT OF SUBSTANTIAL IMPROVEMENTS IN HBA1C AND WEIGHT LOSS ON THE MEDICATION PREFERENCES OF PEOPLE WITH TYPE 2 DIABETES
    Gelhorn, H.
    Osumili, B.
    Brown, K.
    Ross, M.
    Schulz, A.
    Fernandez, G.
    Boye, K.
    VALUE IN HEALTH, 2023, 26 (06) : S312 - S313
  • [46] Levels of circulating semaglutide determine reductions in HbA1c and body weight in people with type 2 diabetes
    Overgaard, V. Rune
    Hertz, L. Christin
    Ingwersen, H. Steen
    Navarria, Andrea
    Drucker, J. Daniel
    CELL REPORTS MEDICINE, 2021, 2 (09)
  • [47] Glycemic Control with Tirzepatide in People with Type 2 Diabetes by Baseline HbA1c=8.5% or >8.5%
    Aleppo, Grazia
    De Block, Christophe
    Levine, Joshua A.
    Gomez-Valderas, Elisa
    Benneyworth, Brian D.
    DIABETES, 2022, 71
  • [48] Association of characteristics of people with type 2 diabetes mellitus with discordant values of fasting glucose and HbA1c
    Rathmann, Wolfgang
    Bongaerts, Brenda
    Kostev, Karel
    JOURNAL OF DIABETES, 2018, 10 (12) : 934 - 941
  • [49] Trends of HbA1c and BMI in People with Type 2 Diabetes: A Japanese Claims-Based Study
    Hara, Kazuo
    Hirase, Tetsuaki
    Pathadka, Swathi
    Cai, Zhihong
    Sato, Manaka
    Ishida, Noriyuki
    Takemura, Ryo
    DIABETES THERAPY, 2024, 15 (04) : 801 - 817
  • [50] Beyond HbA1c cardiovascular protection in type 2 diabetes mellitus
    Adamu, U. G.
    Mpanya, D.
    Patel, A.
    Tsabedze, N.
    JOURNAL OF ENDOCRINOLOGY METABOLISM AND DIABETES OF SOUTH AFRICA, 2023, 28 (01) : 7 - 13
12345